Advertisement

Topics

Sangui BioTech International, Inc. Company Profile

16:30 EDT 23rd March 2019 | BioPortfolio

Revenue Development for the 2013 through 2015


News Articles [2096 Associated News Articles listed on BioPortfolio]

Sangui BioTech: Patent für SBT 102

Die Sangui BioTech International Inc. meldet eine Patenterteilung: Der Schutz wurde vom Europäischen Patentamt ausgesprochen und bezieht sich auf das die Technologie SBT 102 zur Behandlung von Pati.....

DGAP-News: Sangui BioTech International Inc.: - Umsätze von USD 55.367 im ersten Halbjahr; Erfreuliches Jahresendgeschäft (deutsch)

Sangui BioTech International Inc.: - Umsätze von USD 55.367 im ersten Halbjahr; Erfreuliches Jahresendgeschäft DGAP-News: Sangui BioTech International Inc. / Schlagwort(e): Halbjahresergebnis Sangu....

DGAP-News: Sangui BioTech International Inc.: - Umsätze von USD 77.152 im Geschäftsjahr 2018; Kosten und Verlust stark reduziert (deutsch)

Sangui BioTech International Inc.: - Umsätze von USD 77.152 im Geschäftsjahr 2018; Kosten und Verlust stark reduziert DGAP-News: Sangui BioTech International Inc. / Schlagwort(e): Jahresergebnis S.....

DGAP-News: Sangui BioTech International Inc.: Europäische Patentamt erteilt Patent für Verfahren zur Behandlung des Septischen Schocks (deutsch)

Sangui BioTech International Inc.: Europäische Patentamt erteilt Patent für Verfahren zur Behandlung des Septischen Schocks DGAP-News: Sangui BioTech International Inc. / Schlagwort(e): Patent Sang....

Sangui BioTech International Inc.: Patent granted to Sangui for possible Septic Shock treatment

WITTEN / ACCESSWIRE / March 06, 2019 / The European Patent Office has granted a patent for Sangui's proposed technology/treatment (SBT 102) for septic shock patients, effective March, 6, 2019*. The...

Sangui BioTech International Inc SGBI Financial and Strategic SWOT Analysis Review [Report Updated: 27122018] Prices from USD $125

Sangui BioTech International Inc SGBI Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been com...

New PAREXEL division supports emerging biotech companies

PAREXEL International Corporation introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectivel...

Video Round-Up: Biotech Showcase Conference 2019

The Biotech Showcase this year took place in San Francisco and welcomed international and local guests to meet for partnering. The post Video Round-Up: Biotech Showcase Conference 2019 appeared first ...

PubMed Articles [541 Associated PubMed Articles listed on BioPortfolio]

Third-quarter biotech job picture.

New Nonprofit Biotech From Bill and Melinda Gates.

Biotech leaders call for free press.

US law threatens flow of foreign capital to biotech sector.

Genetic data sharing: a new type of capital.

Over the last three decades, various biotech companies, mostly in North America, have become experts in the production, processing and analysis of large volumes of genetic data. They have surpassed th...

Clinical Trials [1148 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Epidogs International Inventory of Seizure Alert Dogs

This international research project looks at the reliability of canine seizure alerting behaviour in epilepsy patients. In the first stage an international database to identify the size an...

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Companies [2242 Associated Companies listed on BioPortfolio]

Sangui BioTech International Inc.

Sangui BioTech International, Inc.

Revenue Development for the 2013 through 2015

Sangui Bio Tech International Inc.

BioExecutive International™

Building the New Biotech Leadership Every issue of BioExecutive International™ provides biotech executives with a learning experience-an opportunity to understand and implement the business building...

SIRION Biotech International Inc.

SIRION Biotech International is a wholly-owned subsidiary of SIRION Biotech GmbH providing custom engineering and manufacturing services of viral vectors for the life sciences ind...

More Information about "Sangui BioTech International, Inc." on BioPortfolio

We have published hundreds of Sangui BioTech International, Inc. news stories on BioPortfolio along with dozens of Sangui BioTech International, Inc. Clinical Trials and PubMed Articles about Sangui BioTech International, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sangui BioTech International, Inc. Companies in our database. You can also find out about relevant Sangui BioTech International, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record